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INTRODUCTION 
 
Superficial parotidectomy is the procedure of choice for patients with any 
inflammation, benign or low grade malignant tumor of the superficial lobe of the 
parotid gland. 
Anatomically, the parotid gland is divided into two lobes, superficial and deep based 
on the course of facial nerve running through the gland. In superficial parotidectomy, 
the superficial lobe is with preservation of the deep lobe and the facial nerve. 
Negative pressure drains are then applied to the surgical bed so as to remove any 
accumulated serous fluid or blood, at a site separate from the incision. These drains 
are then removed later when the drain output is less than 30-50 ml or at surgeons’ 
discretion (usually on 2nd postoperative day). (1)Purpose of the drain is to detect any 
bleed, prevention of seroma formation, and detection of any salivary leak. 
RATIONALE 
Seroma formation rates are highly variable (2% - 44%) (2)(3)(4), depending on 
surgical experience and center where the procedure is being undertaken. While there 
are studies indicating seroma formation of 44% even with drain applied(3), studies 
with early removal of drain even up to 8 hours after the surgery have shown seroma 
formation to be as low as 2%(4). Such wide variation suggests that meticulous 
surgical dissection and hemostasis may be more important factors in preventing 
seroma formation than drain insertion. 
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Hematoma formation is rare in patients undergoing superficial parotidectomy 
especially with meticulous hemostasis achieved, incidence varying from 0 to 6% (5). 
Owing to the clean site of the operation being undertaken and strict asepsis, infection 
of the incision site is not a routine finding (2-11%) (6). 
Temporary facial nerve paralysis is a common complication reported following 
superficial parotidectomy owing to the retraction of the nerve during the procedure 
and there have been no reports of seroma or a vacuum drain accentuating the 
paralysis.  
 
Studies questioning the use of drains in thyroid surgeries have shown no benefit (7) 
with some even showing a disadvantage of having a drain (8). 
Similar studies relating to postoperative drains in laparoscopic cholecystectomy, 
breast surgeries have found to have similar results (9). 
Implications of inserting drain are also to be considered. There is an additional cost 
incurred and in some patients hospital stay may even be prolonged. Also the drain 
acts as a cause for patient discomfort as patient may be unable to lie on the side of 
drain insertion and may have restricted mobility (1). Since the insertion site for drain 
is different from the incision site, there is an added scar as it heals by secondary 
intention (1).The effect of having a suction drain placed over the facial nerve, which 
comes to be superficial after surgery, remains to be evaluated. Although drains are 
inserted so as to remove fluid accumulation and prevent infection, drains may also 
increase the risk of infection by retrograde transmigration of bacteria . Drain sites 
6 
 
can lead to pain in the post-operative period. In the event of drain occlusion, the 
drains may prove harmful by causing a hematoma/ seroma and leading to nidus of 
infection.  
Looking at the significant gaps in knowledge regarding the utility and efficacy of 
drains that exist today , and the lack of a standard protocol for routine drainage, we 
would like to scientifically evaluate the use of drains in superficial parotidectomy. 
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OBJECTIVES 
 
To compare the primary and secondary outcomes of patients undergoing surgery 
of the superficial lobe of the parotid gland on applying a drain on the post- 
operative bed as opposed to not applying a drain in the post-operative bed. 
 
PRIMARY OUTCOME:  
To compare the rate of clinically significant seroma formation in patients with a 
drain applied vs. no drain applied. 
 
SECONDARY OUTCOME:  
To compare the rate of hematoma formation and surgical site infections in 
patients with a drain applied vs. no drain applied.  
To compare both arms on the basis of hospital stay, need for resuturing, drain 
insertion or any further interventions. 
 
 
 
8 
 
LITERATURE REVIEW 
 
HISTORY 
 
 Historically, there has been much controversy regarding the anatomy and hence 
possible surgery of the parotid gland.  At the end of the 19
th
 century it was 
widely believed that the facial nerve travelled entwined with the parotid gland 
and hence it was impossible to operate on the parotid gland without damaging 
the facial nerve. 
The two lobes were first discovered by Gregoire in 1912 on conducting various 
animal studies and he hypothesized that the two lobes were joined by an isthmus 
that lay above the entry of the facial nerve.(10) In 1917, Mcwhortor confirmed 
the existence of two lobes of the parotid gland and hypothesized that the two 
lobes were connected by tissue that lay between the main trunks of the facial 
nerve.  
The bilobed structure of the parotid gland was discovered and accepted much 
earlier by the French and German surgeons  while the English speaking world 
only accepted the surgical anatomy as late as 1942.(11) 
In 1947, Hamilton bailey described the surgical anatomy of the parotid gland as 
it is understood today and attempted superficial parotidectomy while preserving 
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the facial nerve. (11) Of the 77 parotidectomy he performed, 55 were superficial 
parotidectomies and the remaining were extra capsular dissections. 
ANATOMY 
 
The human salivary glands are divided into two groups. Major salivary glands 
are paired and include parotid glands, submandibular glands and lingual glands 
while minor salivary glands range in hundreds which line the upper aero 
digestive tract. The parotid glands are the largest of the salivary glands. The 
salivary glands serve to provide lubrication , to ease in mastication and to start 
the process of digestion with the help of salivary amylase enzymes.(12) 
EMBRYOLOGY  
The salivary glands start to develop in the fetus at 6 weeks of gestation. Solid 
buds of ectoderm line the primitive mouth and begin to invaginate into the 
surrounding mesenchyme. Thus the ducts formed are lined by ciliated epithelium 
while the external aspect consists of myoepithelial cells and stroma.  The blind 
ends of the solid buds go on to form the future parotid glands while the 
remainder forms the Stenson’s duct.  
The development of the salivary glands occurs in three stages. The first stage is 
of Analage formation or the laying of the foundation wherein a solid bud of 
tissue with surrounding primitive ducts are formed.  During the second stage, 
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there is progressive hollowing of the acini and the solid buds. The third stage 
marks the period of progressive maturation and development of the acini and 
reduction in surrounding connective tissue. The facial nerve forms a close 
relation with the developing gland in early embryonic stages and hence is found 
in close relation with the gland. 
GROSS ANATOMY 
The parotid gland is a pyramidal, bilobed paired gland located normally posterior 
to the mandible and the base of cranium, hence a normal gland is not clinically 
appreciable.(13) The parotid gland is encased by a tough fascia which is a 
condensation of the investing layer of the deep cervical fascia.(14) 
The parotid gland is related to the masseter muscle on the medial aspect and 
laterally to the posterior belly of the digastric muscle and the stylohyoid muscle. 
The parotid bed i.e. structures found deep to the deep lobe of the parotid gland 
include the internal jugular veins, the internal and external carotid arteries, the 
last four cranial nerves  and the styloid process with the associated muscles. (13) 
 There is no natural plane found between the gland and the skin and in 
order to access the gland surgeons raise either a subcutaneous or a subplatysmal 
flap. The gland is also found to be tethered by fibrous attachments to the external 
auditory canal, the fibrous layer of the sternocleidomastoid and the mastoid 
process.  
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Several important structures traverse the parotid gland, which include:  
1. the retro mandibular vein 
2. the terminal branch of the external carotid artery that divides into the 
maxillary artery and the superficial temporal artery; 
3. Intraparotid lymph nodes. 
4. branches of the facial nerve(15) 
 
THE FACIAL NERVE 
The facial nerve is closely associated with the parotid gland and arbitrarily 
divides the gland, along with the retro mandibular nerve, into the superficial and 
deep lobe.  The differentiation between the lobes is purely anatomical and there 
is no difference seen microscopically between the two lobes of the parotid gland.  
There is no anatomical plane that exists between the two lobes. 
The nerve exits the skull at the stylomastoid foramen and enters the gland 1 cm 
from the point of exiting the skull.  The Pes Anserinus marks the division of the 
nerve into two major trunks of the facial nerve i.e. the temporal and the 
cervicofacial trunks. These subsequently divide to give rise to the branches 
which are temporal, upper and lower buccal branches, zygomatic, cervical and 
the marginal mandibular nerves. 
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The facial nerve is responsible for the motor innervation of the face and any 
damage to the same may lead to temporary or permanent damage to the function 
of the one side of the face.  
Landmarks commonly used to aid identification of the trunk of the facial nerve 
are: 
1. Conley’s pointer -1 cm inferior and deep to the tip of the inferior portion 
of the cartilaginous canal which  indicates the position of the facial nerve, 
2. The superior border of the posterior belly of the digastric muscle. 
 
Parotid Duct 
It exits the parotid gland from its anterior border to travel parallel to the 
zygomatic bone, about 1cm below it, anterior to the masseter. It takes a sharp 
turn at the buccinator muscle to pierce it, and enter the oral cavity opposite to  
the second upper molar tooth.(16) 
SMAS 
The Superficial Muscular Apo neurotic System is a network of fibers that 
connects the facial muscles with the dermis. It attaches superiorly to the 
zygomatic arch and is continuous with the platysma. The facial nerve courses 
deep to the platysma and the SMAS in the lower face. Within two layers of 
13 
 
parotid fascia, which extend from the zygoma above, the parotid glands are 
contained. 
 
HISTOLOGY  
 
Histologically, the salivary glands are divided into predominantly serous, 
mucous or mixed glands according to the type of secretions produced. The 
functional unit of salivary glands consists of acini, ducts and associated 
myoepithelial cells. 
Serous glands have pyramidal cells with basally placed nuclei which surround 
the lumen. These cells have a clear cytoplasm and are mainly involved in 
secretion of salivary amylase. The serous cell has multiple basophilic granules 
which are diastase resistant and PAS positive. 
Mucinous glands have similar cells with basal nuclei. However the acinar cells 
contain multiples vacuoles containing mucin.The lumen is continuous with 
intercalated ducts into which the secretions are poured. The intercalated ducts 
drain the acini into the striated ducts.  The intercalated ducts are lined by 
cuboidal cells while the striated ducts are lined by columnar cells. 
The striated ducts then lead into the interlobular secretory ducts which are lined 
by pseudo stratified epithelium and occasional mucus cells. 
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Myo-epithileal cells are stellate cells which are noted to surround the acini and 
the intercalated ducts. These are composed of actin- myosin ultrastructure which 
helps in propulsion of the secretions. These cells are located between the 
basement membrane and the basal surface of the acinar cells and contain long 
dendrites that wrap around the cells. These cells are difficult to identify on 
haemotoxylin- eosin staining however are noted on electron microscopy. These 
cells also contain  pinocytic vesicles, lipofuschin and glycogen granules.(17) 
The parotid gland consists of the functional unit as well as intralobular and extra 
lobular adipose tissue which increase with age. The functional unit is mostly 
serous acini. There are multiple septa which divide the parenchyma.  There are 
multiple lymph aggregates and nodes within the parenchyma which are randomly 
distributed in the gland. There may be Neisse Nicholson rests within the nodes 
which are salivary acini or duct rests . 
The submandibular gland is a mixed gland with a predominance of serous 
glands. The sublingual gland is a mixed gland with predominance of mucus 
glands. 
The minor glands of the buccal mucosa and the lateral aspect of the tongue are 
seromucous whereas those in the ventral tongue, retro molarpad, 
glossopharyngeal area and palate are predominantly mucous. 
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PHYSIOLOGY OF SECRETION OF SALIVA 
 
The principal function of the salivary glands is to secrete saliva, which has 
digestive, lubricative and protective functions in the body. 
Secretion 
Within the gland, potassium [K+] concentration is high and sodium 
[Na+]concentration is low. With increasing flow rate, [K+] concentration 
decreases slightly to level off at a constant value, whereas [Na+] concentration 
increases. 
Chloride concentration predominantly follows [Na+] concentration. Except at 
low levels of secretion, bicarbonate [HCO3-] secretion in saliva is hypertonic 
compared to plasma. 
Within the duct, [Na+] and [Cl-] are reabsorbed, whereas [K+] and [HCO3-] are 
secreted. At higher flow rates, less time is available for this exchange and hence 
the concentration is isotonic to plasma. At lower flow rates, [K+] is higher in  
Saliva, [Na+] and [Cl-] are lower, and [HCO3-] remains hypertonic to plasma. 
Mostly, however, saliva is hypotonic to plasma since [Na+] and[ Cl-] 
reabsorption is   greater than secretion of [K+] and [HCO3-]. 
Saliva also contains the compounds alpha amylase, lingual lipase, 
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Lysozymes, glycoprotein, IgA secretory piece and lactoferrin which are detailed 
below. Also secreted are organic blood group antigens A, B, AB and O. The 
protein 
Kallikrein is also secreted by saliva, which converts plasma protein into 
bradykinin. 
Salivary secretion is regulated by both parasympathetic and sympathetic 
branches, but more by the parasympathetic arm, through the facial and 
glossopharyngeal nerves. It leads to acinar activation and ductal transport, 
leading to glandular vasodilatation and myoepithelial cell contraction. 
Subsequent to Acetyl choline stimulation of muscarinic receptors, inositol 
trisphosphate is formed which causes increased Calcium [Ca++] concentration 
intracellularly. The source of this [Ca++] is either from intracellular stores or 
from plasma. Thus, [Ca++] acts as a second messenger which controls the 
volume of salivary secretion. Further secretion is maintained by 
acetylcholinesterases, which inhibit the breakdown of  Acetylcholine (ACh). 
Atropine, the muscarinic antagonist, decreases salivation by competing with 
(ACh) for the salivary receptors.  Sympathetic stimulation is via the superior 
cervical ganglion. It leads to myoepithelial contraction, similar to 
parasympathetic stimulation. Changes in blood flow occur which is biphasic. 
Initial vasoconstriction occurs due to sympathetic stimulation of alpha-adrenergic 
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receptor activation which is followed by vasodilatation due to a buildup of 
vasodilator metabolites. Nor epinephrine binds to alpha adrenergic receptors to 
form cAMP (3'5'Cyclic Adenosine Monophosphate). This leads to protein 
phosphorylation and enzyme activation, with increased mucus content in saliva. 
Antidiuretic hormone (ADH) and Aldosterone affect salivary secretion 
byincreasing [K+] concentration and decreasing [Na+] concentration. However, 
it does not affect the rate of secretion.(12)(18) 
In the unstimulated state, the quantity of saliva secreted amounts to 1 Liter per 
day. Sixty nine percent is contributed by the submandibular glands, 26% by 
parotid, and 5% by the sublingual glands. In the stimulated state, however, 2/3rd 
of the secretion is from the parotid gland. The minor salivary glands produce 7-
8%  of salivary flow regardless of stimulation.  
Stimulants of salivary secretion include the presence of food in the mouth, 
chewing and nausea. Inhibitors include sleep, dehydration, fear and fatigue. 
Role in digestion 
Saliva contains Ptyalin, an alpha-amylase which cleaves the internal alpha-1,4-
glycosidic bonds of starch to form maltose, maltotriose and alpha-limit dextrins. 
Its optimal pH is 7, and rapidly degrades at more acidic pH and readily denatures 
at ph.<4. Even so, it remains active to break down up to 75% of the carbohydrate 
content of a meal within the stomach as effective mixing of the food with saliva 
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takes place in the confines of the stomach. In the absence of Ptyalin, pancreatic 
amylase breaks down carbohydrates within the small intestine. 
Additionally, the lingual salivary glands secrete lingual lipase, which breaks 
down 
triglycerides. 
 
Role in Lubrication 
The mucus constituent of saliva facilitates lubrication of food during chewing by 
mixing with saliva. It eases the process of swallowing. It is also important to 
facilitate speech. 
 
Role in Protection 
Saliva has several antibacterial properties. The secretory piece i.e. a binding 
agent (glycoprotein) for IgA forms a complex with IGA which is active against 
bacteria and viruses. Lysozyme in saliva is antibacterial by causing bacterial 
agglutination and by activating autolysin which degrades cell walls. Lactoferrin 
in saliva is an iron chelator which inhibits the growth of bacteria which require 
iron for survival. 
 
19 
 
Other roles 
Saliva serves as a protective buffer by diluting harmful substances and lowering 
temperature of hot food items. It also helps to clear foul tasting substances. In the 
stomach, it helps to neutralize acid to some extent. Lack of 
salivation, Xerostomia, leads to apthous ulcers, buccal infections and dental 
caries. 
 
EPIDEMIOLOGY 
 
The global annual incidence of salivary gland pathologies varied from 0.4-13.5 
cases per 100,000 population.(17) 
The malignant salivary tumors comprise of 0.4- 2.6 cases per 100,000 
population. There is a geographical variation in the incidence and the type of 
tumors noted.  A seven fold increase in Warthin’s tumor is noted in Denmark 
while the incidence of muco-epidermoid carcinoma in U.K( 2.1 %) is much 
lesser as compared to the world incidence of the same ( 5-15 %). 
In the United states, salivary gland tumors form 6% of all head and neck tumor. 
There is also an ethnicity related variation in the incidence of tumors. The Malay 
population of Malaysia has been reported to have a higher incidence of salivary 
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gland tumors as compared to the Indian or the Chinese resident population. A 
racial predominance is also seen in the white population.(19) Lymphoepithelial 
carcinomas which are noted in 1% of salivary gland carcinomas, have a higher 
incidence in Inuit and Asian populations.(20) 
The parotid gland is the most commonly affected amongst the major salivary 
glands. Of the salivary tumors, the parotid gland tumor contribute about 80-85 % 
of the pathology.(21) 
7-11 % of the salivary gland tumors arise from the submandibular glands while 
less than 1 % arise from the sublingual glands. The minor salivary glands 
contribute 9- 23 % of the pathology.(17) 
The benign tumors of the salivary glands predominate with an incidence of 54-
79% while the malignant tumors range between 21-46%. 
There is peculiar variation in the incidence of malignant tumors with respect to 
the glands affected. The parotid gland is affected by malignancy in 15-32% of 
the patients. 41-45% of submandibular tumours are malignant while 70-90% of 
sublingual tumours are malignant.  50% of minor gland tumours are malignant . 
The floor of the mouth and other minor salivary glands can have  malignant 
tumors 90 % of the time.(17) 
The female gender is more commonly affected however a variation may be noted 
with the type of the tumor.(17)(22) 
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Benign tumors are most commonly seen at the age of 40-50 years while 
malignant tumors are seen more commonly at the age of 50-60 years. (17) 
Of all the salivary gland tumors, Pleomorphic adenoma is most common with an 
incidence of 45-50 %. The second most common pathology is Warthin’s tumor. 
The most common malignancy is muco-epidermoid carcinoma in the major 
glands while the minor glands are most often affected by canalicular adenomas 
and polymorphous low-grade adenocarcinoma. 
ETIOLOGY 
 
Radiation exposure has been noted to have a causative relation with tumor of the 
salivary glands. Following the Hiroshima and Nagasaki atomic bombings, a rise 
in the number of parotid gland tumors was noted.  A life span study of survivors 
of the bombing showed an increase in the incidence of mucoepidermoid 
carcinoma and of warthin’s tumors in patients with increasing radiation 
dosage.(23) 
An increased relative risk of 3.5 for benign and 11 for malignant salivary 
neoplasm was noted in the said populations.(17) 
Exposure to therapeutic radiation  for head and neck carcinomas is also noted to 
have a significantly elevated risk for salivary gland tumors. A series also noted a 
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higher incidence of salivary gland tumors in patients with repeated exposure to 
dental x-rays.(17) 
An increased risk of salivary gland tumor has been noted with patients receiving 
iodine 131 treatment as there is an increased concentration of the same in the 
gland.(17) 
Therapeutic medical radiation treatment to the head or neck  and ultraviolet light 
treatment to the head or neck  were associated with increased risk with an odds 
ratio of 2.6 and 1.9 respectively .(24) 
Multiple viruses have been noted to have an association with salivary gland 
tumors. These include EBV, HIV and SV40. EBV has been noted to have a 
correlation with patients affected with lympho-epithelial carcinoma of the 
salivary glands. A relation has also been noted between SV40 viruses and 
pleomorphic adenoma.(17) 
Patients infected with HIV have also been noted to have a higher risk for 
developing salivary gland carcinomas. In a study conducted in southern Europe, 
the age standardized incidence was 33.6 for HIV positive men to develop 
salivary gland tumors. (25) 
There is no positive correlation proven with HPV virus infections.(17) 
Certain histological types have a predominance noted in patients with HIV 
namely lymphoepithileal and less commonly, squamous cell carcinoma.(20) 
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A definite influence of  environmental factors has been noted in the development 
of both benign and malignant tumors. 
Intake of certain foods rich in Vitamin C has been noted to have a preventive role 
in salivary gland malignancies. Foods rich in cholesterol may pre-dispose to 
salivary gland tumors.(26) 
An increase in incidence of Warthin’s tumors has been noted in patients with 
chronic smoking.(19) 
Occupational exposure to asbestos, nickel, and rubber factories has been noted to 
have a higher risk for development of salivary gland carcinomas.(17) 
Hormonal influence over parotid swellings has been widely studied. An 
associated overexpression of progesterone receptors has been noted in patients 
with recurrent parotid pleomorphic adenoma. 
 
NON NEOPLASTIC PATHOLOGY OF THE PAROTID GLAND 
The salivary glands are affected by benign inflammatory conditions as well as 
tumors. 
Non neoplastic conditions include acute and chronic sialadenitis. 
Sialolithiasis is more commonly encountered in submandibular glands, however 
parotid gland is involved in 6-20 % of the patients affected with the same. 
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Sialolithiasis is more commonly seen in patients with dehydration, gout, trauma 
and smoking. Certain drugs such as diuretic and anticholinergics predispose to 
the formation of these stones(27). 
Acute sialadenitis may be associated with sialolithiasis with complaints of pus 
formation, severe pain and erythema. The same usually subsides with 
conservative management with antibiotics and analgesia, however with recurrent 
disease these patients may require surgical intervention. 
Rarely the patients may have persistent pus discharge with sepsis and complete 
blockage of the parotid duct secondary to the stones which may be indicative of a 
parotid abscess formation. Further evaluation with CT may be required . 
Complete chronic obstruction of the salivary duct leads to subsequent drop in the 
production of the salivary secretion from the affected gland. The gland hence 
becomes firm in consistency and may resemble a focal mass lesion. Such a lesion 
may not require any surgical intervention. 
The most common cause of parotid gland enlargement is viral parotitis secondary 
to mumps. The parotid gland appears to be enlarged within 48 hours of the initial 
prodromal symptom complex. 
 Multiple other viruses have been implicated in the pathogenesis of the same. 
These include coxsackie viruses A and B, Epstein-Barr virus parainfluenzavirus, 
influenza A, and echovirus. 
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Acute suppurative parotitis is most commonly caused due to staphylococcus 
aureus. However in post-operative patients the infection is usually polymicrobial. 
Predisposing factors include elderly patients who have prolonged hospital stay, 
who are intubated or have been dehydrated.(28) 
26 
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NEOPLASTIC CONDITIONS OF THE PAROTID GLAND 
 
Neoplastic lesions of the parotid gland include benign as well as malignant 
lesions of the parotid gland. 
The parotid gland is most commonly affected by benign lesions as mentioned 
above. 
Pleomorphic adenoma is the most common tumor to affect the salivary glands. 
Of all pleomorphic adenomas, 80 % arise from the parotid gland, while 10 % 
arise from the submandibular and the sublingual glands. The lower pole of the 
parotid gland is the most commonly affected. These tumors are usually well 
circumscribed and encapsulated, however the capsule may have a variable 
thickness. These are mixed tumors histologically as the cells are usually 
epithelial or myoepithelial in origin while the stroma is usually myxoid or 
chondromyxoid in appearance. These tumors are usually slowly progressive, 
painless and may very rarely have any neural involvement. (17) 
Recurrence rate after surgery for pleomorphic adenoma varies from 1.6 – 3.4 
%.(29) (6) 
Warthin’s tumor is a benign disease almost exclusive to the parotid gland.  It is 
commonly referred to by multiple synonyms such as papillary cyst adenoma 
lymphomatosum ,cystadenolymphoma and adenolymphoma.(30)  The lesion 
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presents as a painless cystic, fluctuant swelling in the parotid gland. A strong 
causal association has been noted with cigarette smoking.(19) 
Histologically, Warthin’s tumors are well demarcated, thinly encapsulated 
lesions with both solid and cystic components. These lesions tend to be bilateral 
in 5-18 % of the patients.(30)(17) 
Basal cell adenoma is a rare pathological diagnosis in patients with parotid 
swelling. These are usually basaloid neoplasms of the parotid gland having 2 
populations of epithelial cells. These may have various histological types 
according to the density of cell distribution. These are usually well treated with 
surgery of the lesion or the affected lobe.(31)(32) 
Malignant salivary gland tumours are divided into two distinct 
Sub-groups: 
1 Low-grade malignant tumor, e.g. acinic cell carcinoma, may mimic benign 
conditions clinically. 
2 High-grade malignant tumours usually present as painless rapidly growing 
swellings in the parotid region. The tumors may present as discrete masses in the 
gland with infiltration of the skin. They may also present as diffuse induration in 
the region of the parotid gland with no obvious mass. 
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Table  Classification of salivary gland tumours (simplified)  
Type  Sub-group  Common examples  
I Adenoma  
Pleomorphic  
 
 
Monomorphic  
Pleomorphic adenoma  
 
 
Adenolymphoma (Warthin’s 
tumors)  
 
II Carcinoma  Low grade 
 
 
 
 
 
 High grade  
Acinic cell carcinoma 
Adenoid cystic carcinoma 
Low-grade muco-epidermoid 
carcinoma  
 
Adenocarcinoma Squamous 
cell carcinoma High-grade 
muco-epidermoid carcinoma  
 
III Non-epithelial 
tumours  
 Haemangioma, 
lymphangioma  
 
 
IV Lymphomas  
Primary lymphomas 
Secondary lymphomas  
Non-Hodgkin’s lymphomas 
in Sjögren’s syndrome  
 
 
V Secondary 
tumours  
Local Distant  
Tumours of the head and 
neck especially Skin and 
bronchus  
 
 
VI Unclassified 
tumours  
 
  
VII Tumor-like 
lesions  Solid lesions Cystic 
lesions  
Benign lymphoepithelial 
lesion Adenomatoid 
hyperplasia Salivary gland  
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TREATMENT 
 
Superficial parotidectomy is the standard treatment of benign as well and low 
grade malignancies of the parotid gland. The procedure involves removal of the 
parotid gland lying anterior to the facial nerve while delineating its anatomy and 
preserving it. 
The surgery is undertaken under endotracheal intubation. Local infiltration is 
advised to allow ease of dissection and to help define planes. The surgery is 
carried out in stages. 
INCISION AND RAISING THE FLAP 
A ―Lazy S‖ incision as described by Blair is marked at three different points to 
facilitate cosmetic closure. The incision runs in  a  slight  S-curve  from  the  
preauricular  incision halfway down the neck.(15)  A modified facelift incision 
with a SMAS flap is also described by some authors.(2) 
Scalpel or scissors are used to develop the skin flap in an anterior direction. The 
plane of dissection is well below the hair follicles, just above the parotid fascia. 
The skin flap is raised beyond the anterior border of the gland. The incision is 
undermined posteriorly in the cervical region allows access to the anterior aspect 
of the sternomastoid muscle. 
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Fig1: Marking of the modified Blair incision 
 
MOBILISATION OF THE GLAND 
The objective of this stage is to free the posterior aspect of the gland so as to 
identify and preserve the facial nerve. 
Two avascular planes are developed – along the anterior aspect of the 
sternocleidomastoid muscle and along the anterior border of the bony and 
cartilaginous external auditory meatus anterior to the tragus. The two planes are 
then joined by a combination of scissor and blunt dissection. 
The external jugular vein is often encountered at the lower end of the dissection, 
and is ligated. The gland is gradually mobilized after identifying the posterior 
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belly of the digastric muscle by sharp dissection up to the anterior aspect of the 
mastoid process. 
LOCALISATION OF THE FACIAL NERVE 
The facial nerve is identified by markers as described above.  Hemostasis must 
be attained prior to and during identification of the facial nerve.  During 
dissection, only a bipolar cautery should be used and even that should be avoided 
in close proximity to the nerve to avoid any thermal or electric injury to the 
nerve. 
Immediately lateral to the nerve, lies the stylomastoid artery, damage to which 
can lead to bleeding and obscure the vision of the operating surgeon. 
Adrenaline soaked gauze can aid in controlling ooze during this phase of surgery. 
After localization of the facial nerve, sharp dissection is carried out just anterior 
to perineural space and the gland is mobilized from a superior to inferior fashion. 
Any branch of the nerve adherent to the tumor may require to be sacrificed. 
Hence a reconstruction can be carried out using the greater auricular nerve. 
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CLOSURE 
The incision is closed in layers after ensuring hemostasis. The classical 
description of the surgery requires a vacuum suction drain to be placed in the 
post-operative bed which is removed 24-48 hours after the surgery. (15) 
 
Adequate parotidectomy is defined as a surgery of the superficial lobe of the 
parotid gland wherein only the affected portion of the lobe is excised. This 
surgery can be undertaken in patients with a proven benign lesion with almost no 
risk of malignant transformation. 
 
COMPLICATIONS OF SURGERY 
 
Complications of parotid gland surgery include: 
 Infection. 
 Hematoma formation 
 Transection of the facial nerve and permanent facial weakness 
 Temporary facial nerve weakness 
 Seroma 
 Facial numbness 
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 Permanent numbness of the ear lobe due to great auricular nerve injury 
 Frey’s syndrome / gustatory sweating due to aberrant innervation post 
operatively 
DRAINS AND THEIR USAGE IN GENERAL 
Suction drains are applied routinely in the surgical practice and done so for a 
variety of reasons such as: 
 To prevent the accumulation of fluid (pus, blood and serous fluids). 
 To minimize dead space. 
 For early detection of any anastomotic leak  
 
Types of drains: 
Open or closed 
    Open drains (Including plastic sheets or corrugated rubber) drain fluid on into 
a stoma bag or a gauze pad. They are likely to increase the risk of infection. 
    Closed drains are formed by plastic tubes draining into a reservoir.AS the 
system is closed, the risk of infection is reduced. 
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Active or passive 
    Active drains are drains acting by negative pressure (which may be low or 
high pressure) with an intention to actively remove any fluid static in the post-
operative bed. 
    Passive drains have no suction and work according to capillary action and the 
differential pressure between body cavities and the exterior. Intra- abdominal 
drains are usually passive drains so as to avoid any vital structures being pulled 
into the drain due to the vacuum applied. 
According to composition 
    Silastic drains are relatively inert and induce minimal tissue reaction. 
    Red rubber drains can induce an intense tissue reaction, sometimes allowing a 
tract to form (this may be considered useful - for example, with biliary T-tubes). 
Suction drains are used regularly for surgeries of the head and neck. These can 
further be sub-divided into high negative pressure and low negative pressure 
drains. High negative pressure drains typically drain into a bottled reservoir 
while low negative usually drain into a bulb reservoir or a four way vacuum 
drain. 
These drains are usually inserted at a site separate from the incision. 
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High negative pressure drains consist of a plastic reservoir with indicator wings 
which help in monitoring vacuum pressure and an opening to allow drainage.  As 
these are closed-circuit, sealed systems, they are safer and easier to monitor and 
allow for safe disposal of drained fluids. 
These drains are typically emptied every 24-48 hours and are typically removed 
after their function is served. According to quantity and quality of fluid draining, 
the drains are removed. 
COMPLICATIONS OF DRAINS• 
1. Breakage—Drains are made of strong polyvinyl chloride plastic or 
silicone and are therefore not expected to break. However, breakage can 
occur during removal of the drain. Surgical exploration may be required if 
breakage does happen. 
 
2. Difficulty in removal— it may become difficult to remove a drain if it 
remains inserted for a long time. Sometimes the drain may be sutured onto 
the underlying tissues. The wound may have to open to facilitate removal 
of the drain. Hence the scar would have to heal with secondary intention 
with a poor scar. 
• 
37 
 
3. Inadvertent removal—Drains may get caught in other tubing or wires and 
may get pulled out.  This may lead to pain and bleeding. 
4. Infection—though drains are inserted to prevent accumulation of fluids 
and hence any infection, they may lead to a retrograde spread of infection. 
Typically, drains are removed as soon as they are draining a small volume 
(e.g., < 25 mL per day; < 1 mL per hour) to reduce this risk. 
5. Occlusion—Drain tubes can become blocked by blood clot, omentum, or 
tissue. This can lead to the formation of a seroma or a hematoma and can 
actually serve as a nidus of infection. 
6. Pain—Drain sites can be tender and may prevent the patient from lying on 
the side of insertion. Some patients may have restricted mobility due to 
apprehension regarding the drains and hence may be more prone to have 
deep venous thrombosis. 
7. Unsightly scar—a drain site may form a pigmented scar as it heals by 
secondary intention. To avoid this, the drain should be brought out in a 
skin crease. 
8. Visceral perforation— drains, if left for a long duration, can erode into 
viscera. 
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Fig 2: Closed suction drains 
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IN DEPTH ANALYSIS OF KEY STUDIES 
There has always been controversy regarding the role of post-operative drainage. 
Multiple studies have evaluated the need for post-operative drainage following 
various surgical procedures. 
The rationale for placing drains varies according to the location and nature of the 
surgery being carried out. 
While in thyroid surgeries, the concern is regarding possible hematoma 
formation and subsequent airway compromise, the use of drains in patients 
undergoing breast or hernia repair is to prevent possible seroma and wound site 
infection. 
Traditional wisdom was for placement of drains, however with a view of the 
possible complications arising from drains, there has been quite a controversy 
over the past few decades regarding the actual advantage offered by drains post 
operatively. 
Even intra- abdominal surgeries such as laparoscopic cholecystectomy which 
traditionally required drainage have been found to have no advantage with 
placement of drains. A Cochrane meta-analysis  was undertaken by Gurusamy et 
al reviewed 12 studies with 1831 participants of which 915  were randomized to 
drain versus 916 participants randomized to ’no drain’ .  There was no significant 
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difference noted between the two after analysis on the basis of complications and 
ease of detection of the same.(33) 
In South Korea, a randomized controlled trial looked at the use of insertion of a 
Jackson Pratt drain in the pediatric population with perforated appendicitis. 
There was surprisingly a higher chance of complications especially formation of 
intra- peritoneal abscess formation in patients with drains placed post operatively 
(22.2% vs. 6.8%, P = 0.00 2). The hospital stay was also noted to be prolonged in 
the drain arm.(34) 
 
In colorectal surgery, drains are expected to prevent abscess, fluid collection or 
hematoma formation or to act as an indicator of postoperative complication, or to 
reduce the severity of complications.  However drains have been found not to 
have any use in any of the above mentioned proposed functions.  A  Meta- 
analysis by Tsujinaka et al showed reduced complications in the non-drain 
group.(35) 
POST OPERATIVE DRAINAGE OF THYROID:  
 
Studies as long back as 1988 , as done by Wihlborg et al showed no advantage of 
drains being placed after routine thyroid surgery.(36) 
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A prospective randomized controlled trial by Suslu et al, comparing outcomes for 
patients with regards to drainage in patients undergoing uncomplicated thyroid 
surgery found no advantage of placing a drain in the post-operative bed. (37) 
A similar study was undertaken by Khanna et al which showed that placement of 
drains after routine thyroid surgery may actually increase fluid collection rather 
than reduce it. The formation of seroma or hematoma was not related to the size 
of nodule or type of surgery. The drain was found notto influence complications, 
and instead lead to an extra scar. Patients who could not be discharged with 
drains actually were noted to stay longer in the hospital. Hemostasis and finesse 
of dissection were considered more important factors in determination of seroma 
formation.(8) 
A study conducted by Deveci et al in Turkey conducted a randomized controlled 
trial with patients following thyroidectomy and compared the length of hospital 
stay, postoperative pain, complications, and volume of fluid collected in the 
operative bed. There was no significant difference in the outcomes noted in the 
patients with drains as compared to those with no drains. A significant difference 
was noted with regards to hospital stay which was prolonged for patients with 
drain placed.(7) 
 
42 
 
A Cochrane meta- analysis conducted by Samraj and Gurusamy compared 13 
randomized controlled studies with 1646 participants. 11 studies compared no 
drainage with drainage and found no difference in re-operation rates; wound 
infections and incidence of respiratory distress. Post-operative seromas/ 
hematomas needing drainage or aspiration were significantly decreased by drains 
(RR 0.51, 95% CI 0.27 to 0.97), but no significant difference  was noted after 
further analysis of the 4 high quality studies (RR 1.82, 95% CI 0.51 to 6.46).(38) 
Further a significant increase in the duration of hospital stay was noted in 
patients with drains in situ. 
 
While the above studies commented on routine thyroidectomy and excluded any 
additional procedures of the neck simultaneously, a randomized controlled trial 
by Lee et al found no advantage of drainage in patients undergoing 
thyroidectomy with central neck dissection. A significant decrease in hospital 
stay was noted in patients with no drainage was noted with a p value of < 
0.05.(39) 
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HEAD AND NECK & PAROTID SURGERY 
Parotid surgeries have traditionally had a drain placed post operatively to prevent 
any complications. However, theneed for drainage and its optimal duration has 
not been defined.It is accepted in general to remove the drain if the 24 hour 
output is between 15- 50ml, varying upon the institution’s protocol. 
A case control study by Chen et al described post-operative drainage in patients 
undergoing partial superficial parotidectomy. A significant drop in post-operative 
drainage was noted within 24 hours of insertion of drains.  Hence chen at al 
suggested that the removal of drains should happen within 24 hours of 
insertion.(40) 
 
Mofle and Uquahart conducted a study in Wisconsin with 69 patients undergoing 
superficial parotidectomy. They advocated early removal of drain  within 8 hours 
of the surgery and reported an incidence rate of seroma of around 2 %.(4)  A 
prolonged hospital stay was noted in patients with late removal of drains and the 
drainage was noted to be considerably higher in patients with malignant 
pathology compared to benign pathology. 
A Randomized controlled trial conducted by Jiang et al compared patients 
undergoing superficial parotidectomy and assigned patients into a pressure group 
and a suction group. Patients in pressure group had a pressure bandage 
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placedafter removal of drains while suction group had a drain placed throughout 
the procedure. The drain was removed once the output dropped to less than 20 ml 
in 24 hours. There was no significant difference in the incidence of salivary 
fistulae or seroma for patients in either group.(41) 
A prospective study was undertaken by Harris et al to look at post-operative 
drainage in patients undergoing major head and neck surgery. 47 patients were 
included in the study and the drain was removed after 24 hours once the volume 
dropped below 50 ml. The rate of seroma formation was found to be 9 % .A 
comparison was made retrospectively with 22 patients having undergone 
surgeries at another center. The drains in these patients were not removed till a 
drop to25 ml over 24 hours was noted. Early removal of drain was found to have 
a significant drop in hospital stay.(42) 
 
Plaza et al conducted a case control study in Spain observing the outcomesof 
partialsuperficial parotidectomy. Partial superficial parotidectomy(PSP) was 
defined as removal of a cuff of surrounding parotid gland, but not of normal 
parotid tissue away from the tumor. While the incidence of the serious 
complications such as nerve injury etc.was lesser in the PSP arm, the incidence 
of seroma was significantly higher.They found the incidence of seroma 
formation to be 28 % in PSParm as compared to 16 %  in superficial 
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parotidectomy in the post-operative period with drains placed in situ in both 
arms.(43) 
Witt et al conducted an observational study regarding the formation of 
sialocoeles after partial superficial parotidectomy as compared to near total 
parotidectomy. 100 consecutive partial superficial parotid surgeries and 20 
consecutive near-total parotidectomy procedures for formation of a postoperative 
sialocoele were studied. Evaluation for sialocoele formation was done at 1 week 
and 1 month postop. The initial 18 sialocoeles were treated with aspirations 
while the last 21 sialocoeles were treated with observation. Pressure dressings 
were not used for either group and the drains were removed on the first post-
operative day. It was found that there was no difference in the outcome in the 
patients for whom aspirations were done as compared to those for whom 
conservative measures were followed. The sialocoeles resolved within 1 month 
of the surgery. The authors also added that repeated aspirations led to fluid 
collecting the dead space within 24 hours of aspiration and hence advised only 
conservative management of seromas.(44) 
A retrospective study by Nourei et al looked at the incidence of complications 
after surgery for benign lesions of the parotid gland. They postulated that a 
higher incidence of salivary fistula and sialocoeles was noted in patients 
presenting with sialadenitis as compared to benign lesions.(6) 
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Tuckett et al studied post-operative complications and found that the extent of 
resection of the parotid gland was a significant factor determining outcomes.  An 
overall incidence rate of 16.7 % was noted for formation of 
sialocoeles.Sialocoele was defined as a postoperative fluid-filled neck swelling, 
confirmed by aspiration of fluid. A salivary fistula was defined as leakage of 
fluid through the neck wound during the postoperative period when 
eating.Complications were treated by compression dressings and serial aspiration 
of fluid collection, until resolution.The authors found that the risk of facial nerve 
injury increased with increasing extent while the risk of sialocoeles and salivary 
fistulae were inversely proportional to the extent of resection.(45) 
A search for studies using PubMed, google scholar and EuropePubMed did not 
yield any randomized controlled studies comparing the use of drains in 
comparison to no drains in parotid surgery.  
Though classically drains are used for parotid surgeries, their drainage is seen to 
be less than the defined significant volume within 8- 24 hours. Furthermore the 
incidence of seroma varies from 2- 44 % in spite of a drain being placed in the 
operative bed. On the basis of available literature, it is evident that drains may 
not be necessary after 24 hours. Also, the rates of sialocele seem to be influenced 
based on the pathology, extent or surgery. 
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 When seroma/sialocoele does occur, serial aspirations do not seem to alter the 
outcome and conservative management without aspiration was found be equally 
effective.   
Various studies have found multiple other confounding factors which may be 
responsible for seroma such as type of surgery, use of surgicel, operating time 
etc. The time of removal of drain has been defined as within 24 hours of surgery. 
Furthermore multiple studies done in other parts of the body have shown that 
drains contribute significantly to patient discomfort, prolonged hospital stay and 
hence cost of treatment. 
It was hence our intention to evaluate the need for post-operative drainage in 
patients undergoing surgeries of the superficial lobe and any arising wound 
complications. 
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RESEARCH QUESTION 
 
We proposed a research question to see: ―Is there any difference in surgical  
outcomes and post-operative complications in patients undergoing surgery 
 of the superficial lobe of the parotid gland on application of drains as  
compared to omission of the same.  We hence proceeded with a  
prospective, randomized controlled, non-inferiority trial to assess the 
 outcomes in patients undergoing superficial parotidectomy especially the 
 incidence of clinically significant seroma. 
 
 
NULL HYPOTHESIS 
 
 
There is significant difference in outcomes in patients, with an advantage  
noted in patients having a drain being placed post operatively after 
 surgery of the superficial lobe of the parotid gland. 
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METHODS 
Institutional Review Board (IRB) and Ethics Committee approval was obtained. 
(Appendix 1) 
All patients diagnosed with superficial parotid tumours were referred to our 
department. An informed consent was obtained (See Appendix) in the patient's 
own language. 
INCLUSION CRITERIA 
Patients diagnosed to have benign parotid pathology and undergoing surgery of 
the superficial lobe of the parotid gland were included in the study. 
 
EXCLUSION CRITERIA 
A. Patients aged <18 years of age 
B. Pregnant women 
C. Patients on anticoagulant therapy 
D. Patients undergoing additional head and neck procedures at the time of 
parotidectomy 
E. Any on-table conversion to total conservative parotidectomy or radical 
parotidectomy due to gross findings suggestive of malignancy. 
F. Not consenting 
G. Clinical and histopathological evidence of malignancy prior to surgery 
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METHODOLOGY 
 
 Method of randomization: Subjects were randomly allocated into 
either of the arm by block randomization. 50%, 25% and 25% 
blocks of 6, 4 and 2 will be done respectively. This was done using 
SAS software. 
 Method of allocation concealment: Sealed Opaque envelops 
generated by computer software as described above by the 
biostatistician. 
 Blinding and masking: The trial was a non-blinded, non-masked 
study in view of the nature of intervention and outcomes under 
comparison. 
Primary Outcome: Incidence of clinically significant seroma in the post -
operative period{ time frame : up to 1
st
 OPD visit} 
Defined as post-operative swelling which is confirmed by the aspiration of clear 
fluid from the same. 
Seroma was graded as per Common Terminology Criteria for Adverse 
Eventsversion 3.0 (CTCAE): 
   grade 1: Asymptomatic. 
   grade 2: Symptomatic; medical intervention or simple aspiration indicated. 
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Grade 3: Symptomatic, interventionalradiology or operative intervention 
indicated. 
 
Proportion of seromas formed in patients having drained in situ was compared 
with those not having drain in situ. 
 
Secondary Outcome: 
1. Hematoma formation 
2.Wound site infection as per CDC CRITERIA 
SUPERFICIAL INCISIONAL SURGICAL SITE INFECTION  
 Infection occurs within 30 days  
  involves only skin and subcutaneous  tissue of the incision  
  at least one of the following:  
1. Purulent drainage from the superficial incision  
2. Organisms isolated from an aseptically obtained culture of fluid or tissue from 
the superficial incision  
3. At least one of the following signs or symptoms of infection: pain or 
tenderness, localized swelling, redness, or heat and superficial incision is 
deliberately opened by surgeon, unless incision is culture-negative  
4. Diagnosis of superficial incisional SSI made by a surgeon or attending 
physician 
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3. Prolonged hospital stay 
4. Gaping of the wound 
5. Need for resuturing 
6. Repeated opd visits 
7. Need for antibiotics 
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Target sample size and rationale: 
Non-inferiority - Two Groups - Parallel – 
Two proportions - Equal Allocation 
  
Proportion in the standard treatment 0.2 0.2 0.2 
Proportion in the new treatment  0.2 0.2 0.2 
Observed/Expected difference in proportions 0 0 0 
Non-inferiority margin -0.15 -0.18 -0.19 
Power (1- beta) % 80 80 80 
Alpha Error % 5 5 5 
Required sample size in each group 88 61 55 
    
 Hence a median sample size of 50 was taken in each arm with a total sample 
size of 100. 
 We consider that a difference in the rate of complications of less than 5% is of 
no clinical importance and the non-inferiority margin was chosen to be 5%. The 
sample size was established at 50 patients in each group to provide appropriate 
statistical power analyses 
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Statistical Analyses:  
Data was screened for extreme values and outliers using Box-Cox plot and 
histograms. Data was entered using EPIDATA software and analyses using 
Excel. Per Protocol and Intention to treat analyses were done. The difference in 
seroma rates was presented with 95% CI. The conclusion was based on whether 
the lower limit covers the non-inferiority margin or not. 
PROTOCOL 
The patients were randomized at the end of the surgery, prior to skin closure, to 
prevent any bias. A 200 mlVario drain was applied in the post-operative bed. The 
patients were then shifted to the ward and monitored. They were monitored for 
any obvious swelling, seroma formation, facial nerve function, hematoma 
formation or surgical site infections. 
 The patients were then discharged as per the protocol described below and asked 
to review in the next OPD – 5-7 days from the surgery. Suture removal was 
routinely done at this time. In case of any complications, they were advised to 
report to the ward or inform the investigator by telephone. 
1. Drain arm: The drains were emptied every 24 hours and were kept till the 
output was less than 30 ml over 24 hours. If the drain was removed for 
any other reason, the reason for the same was documented.The patients 
were discharged either on the day of drain removal or with the drain if the 
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volume was higher than 30- 50 ml. If the patients were discharged with 
the drain, they were taught regarding management of the drain and were 
asked to review in the outpatient department. 
2. Non drain arm: the patients were shifted to the ward and were discharged 
on the next day if there were no complications. In case of any 
complications, the same was documented. 
 
OUTPATIENT DEPARTMENT: 
The patients were instructed to report on 5
th
- 7
th
 day post-operative to 
OPD. They were evaluated for any evidence of seroma, hematoma, 
surgical site infection and facial nerve function. Any abnormality was 
reported to the senior surgeons in the unit and findings were confirmed 
prior to any  
Intervention. Sutures were removed by the 7
th
post-operative day. 
The patient was also asked to report to the OPD for the biopsy and was 
assessed at the same time. 
If a patient was found to be fit by this time, he/ she were declared to be fit 
for discharge from Vellore. 
 
In case of a clinically significant seroma, under aseptic precautions, the 
same was aspirated and the volume was documented. The patient was 
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subsequently asked to report to the ward on a daily basis or in case of 
worsening of symptoms.  In case of persistent drainage requiring multiple 
aspirations, a pressure dressing was applied and if there was no relief, a 
drain was inserted under aseptic precautions. In case of seroma, the 
removal of sutures was delayed as wound healing was expected to be 
prolonged. The wound was serially inspected for gaping, in which case 
the surgical site was resutured. 
Repeated OPD visits, prolonged stay in Vellore were recorded. 
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CONSORT DIAGRAM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Total parotid surgeries = 112 
Benign pathology =87 
Malignant = 19 
Infective/ abscess = 6 
 
 
 
Excluded (n= 69) 
 Not meeting inclusion criteria (n=28  
) 
 Declined to participate (n= 15 ) 
 Other reasons (n=26  ) 
Clinically significant Seroma = 3 
Lost to follow-up (n=0) 
Discontinued intervention (n=0) 
Allocated to drain (n=24) 
 Received allocated intervention (n= 26 ) 
 Did not receive allocated intervention (n=0  ) 
Lost to follow-up (n= 0) 
Discontinued intervention  (n=0) 
Allocated to No drain (n=19) 
 Received allocated intervention (n=17 ) 
 Did not receive allocated intervention   
    (n= 2 ) 
Clinically significant seroma = 9 
 
Allocation 
Analysis 
Follow-Up 
Randomized (n=43) 
Enrollment 
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RESULTS 
 
A total of 45 patients were recruited during the study period. 2 patients were 
excluded from the analysis due to conversion to total conservative or radical 
parotidectomy. 24 were randomized to drain arm while 19 were randomized to 
No drainarm. Of the 19 patients randomized to the no drain arm, 2 patients had a 
drain placed due to intra- operative findings at the end of the surgery at the 
discretion of the surgeon. Both Intention to treat (ITT) analysis and per protocol 
(PP) analysis was done to derive the results. 
The patients were analyzed as per epidemiological parameters as well as for 
outcomes such as incidence of seroma, hematoma, and surgical site infections. 
 
 
 
 
 
 
59 
 
 
DEMOGRAPHICS 
1. Gender  
Of the 43 patients recruited, 31 were males (72.09%) while the remaining were 
females (27.91%). 
 
Fig.3 The ratio of males and females in the sample population 
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2. Duration of complaints  
20 of the patients had complaints for the past 1- 5 years, while 12 had 
complaints for less than 1 year. 6 patients had complaints of parotid 
lesions for the past 5- 10 years while 5 had complaints for more than 5 
years. 
 
 
Fig4:  Pie chartdepicting duration of complaints 
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3. Side of lesion 
          There was an equal distribution with regards to the side affected. Right 
sided lesions were 21, 20 of the lesions were left sided while 2 patients had 
bilateral lesions. 
 
 
Fig.5:  Laterality of lesion 
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4. Address  
A majority of the patients were from West Bengal (18 patients, 41.86%), 
Tamil Nadu (10 patients, 23.26%) and Jharkhand (7 patients, 16.28%).  2 
of the patients were from Bangladesh (4.65 %). 
 
 
Fig 6: The demographic profile of patients undergoing superficial 
parotidectomy at our center. 
 
4
2
7
1
10
1
18
0
2
4
6
8
10
12
14
16
18
20
andhra 
pradesh
bangladesh jharkhand Kerala tamil nadu tripura west 
bengal
63 
 
5. Comorbid illnesses 
Of the 43 patients originally recruited, only 14 had prior comorbid 
illnesses.16.28% of the patients were known diabetics while 9.3 % 
patients were affected with hypertension. 
Totally 68.89 % of the patients had no prior comorbid illnesses while 
31.11 % had prior comorbid illnesses. 
 
Fig.7: Frequencies of comorbidities in our patients 
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6. Prior surgeries 
3 of the total patients recruited had been operated earlier. 
Table 1: Frequency of prior surgery 
prior Frequency Percent 
Cumulative 
Frequency 
Cumulative 
Percent 
No 40 93.33 42 93.33 
Yes 3 6.67 45 100.00 
 
Table 2:Time elapsed since previous surgery 
Duration Frequency Percent 
Cumulative 
Frequency 
Cumulative 
Percent 
< 1 year ago 1 33.33 1 33.33 
>1 year ago 2 66.67 3 100.00 
 
 
Two of the patients had ipsilateral lesions operated while one had a contralateral 
lesion operated upon. 
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Table 4: The drain output according to the post-operative day 
 
The drain arm was monitored every 24 hours and output was recorded. 
The majority of the patients had the drain removed at 48 hours after 
surgery. The median volumes draining on the first and second post-
operative day were 35 and 30 cc respectively.  
 
Variable N Median Minimum Maximum 
POD 1 output 
 
 
POD2 Output 
 
 
POD3 output 
 
 
POD4 output  
 
 
 
Date of drain 
removal 
 
 
25 
 
 
15 
 
 
4 
 
 
3 
 
 
 
25 
35.000000 
 
 
30.000000 
 
 
50.000000 
 
 
30.000000 
 
 
 
3.0000000 
5.0000000 
 
 
0 
 
 
40.000000 
 
 
30.000000 
 
 
 
2.0000000 
90.0000000 
 
 
90.0000000 
 
 
75.0000000 
 
 
80.0000000 
 
 
 
6.0000000 
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Fig.8: Drain removal since the day of surgery 
REASON FOR DRAIN REMOVAL: 
The reason for the removal of drain was also documented during the 
course of the study and was divided into the following categories: 
 <30 ml 
 surgeon’s discretion 
 nonfunctional 
 slipped out 
 others 
7
12
4
1 1
0
2
4
6
8
10
12
14
24 hours 48 hours 72 hours 96 hours 120 hours 
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Only one patient was discharged with drain and was advised follow up on OPD 
basis. 
Table 5: Reason for drain removal 
 
Frequency Percent 
Cumulative 
Frequency 
Cumulative 
Percent 
< 30 ml
output  
23 95.83 23 95.83 
Slipped out 1 4.17 24 100.00 
 
 
It is common practice to remove the drain as soon as it is less than 30 ml 
over 24 hours. 
95.83 % of the patients in the drain arm had drain removed for this reason. 
Only 1 patient had the drain slipping out before a drop in output. 
Biopsy 
Patients with benign pathology, as per clinical and fine needle aspiration, were 
included in the study.  However,any patients found to have malignancy after 
histopathological assessment were included in the study and followed up as per 
the protocol described above. 
Majority of the patients operated had pleomorphic adenoma (48.84%) while 
Warthin’s tumor was the second most common pathology. 
68 
 
Table 6: Histopathology of the lesions excised 
Biopsy Frequency Percent 
Cumulative 
Frequency 
Cumu 
lative 
Percent 
basal cell adenoma 4 9.30 4 9.30 
Kimura's disease 1 2.33 5 11.63 
lipoma parotid 1 2.33 6 13.95 
low grade mucoepidermoid carcinoma 3 6.98 9 20.93 
malignant salivary neoplasm- mammary analogue 
carcinoma 
1 2.33 10 23.26 
mild chronic sialadenitis 1 2.33 11 25.58 
Myoepithelioma 1 2.33 12 27.91 
pleomorphic adenoma 21 48.84 33 76.74 
salivary gland fatty infiltration 1 2.33 34 79.07 
sinus tract with granulation tissue 1 2.33 35 81.40 
warthin's tumor 8 18.60 43 100.00 
 
Of the 43 patients included, 4 patients were diagnosed to have low grade 
malignancies on histopathological assessment of which 3 were low grade muco-
epidermoid carcinoma while 1 patient had mammary carcinoma analogue. 
1 patient had chronic sialadenitis. 1 patient underwent parotidectomy for a 
branchial fistula and the pathology for the same was reported to be a sinus tract 
with granulation tissue. 
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Fig. 10: Histopathology of the lesions operated upon   
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SEROMA IN COMPARISON TO DRAIN INSERTION 
There were 43 patients who were recruited as per our protocol. 24 were 
randomized to drain group while 19 were randomized to no drain group.  
However, 1 patient who wasrandomized to no drain arm eventually had a drain 
placed, as per the decision of the surgeon (protocol violation). Hence we have 
analyzed our results as per Intention to treat as well as per protocol analyses. 
12 patients were detected to have clinically significant seroma requiring an 
intervention. Of these, 9 patients were in no drain arm and 3 were in drain arm. 
The overall incidence rate was 27. 90 %, with 20.9 % arising in the non-drain 
group. 
 As per Per Protocol analysis: 
Table 7: Seroma formation Vs. drain application 
Frequency 
Percent  Drain 
 
Seroma No  Yes  Total 
No  8 
18.60 
 
23 
53.49 
 
31 
72.09 
 
 
Yes  9 
20.93 
 
3 
6.98 
 
12 
27.91 
 
 
Total 17 
39.53 
26 
60.47 
43 
100.00 
P value as per this result was 0.0052  and was deemed significant 
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ITT ANALYSIS: 
 
Table 8: seroma formation vs. randomization to drain  
Frequency 
Percent Randomization  
 
Seroma Drain  
No 
drain  Total 
NO 22 
51.16 
 
9 
20.93 
 
31 
72.09 
 
 
YES 2 
4.65 
 
10 
23.26 
 
12 
27.91 
 
 
Total 24 
55.81 
19 
44.19 
43 
100.00 
 
The P value as per ITT analysis was 0.002 and was also considered significant. 
The above results show that the incidence of Clinically significant seroma was 
significantly higher in the patients with no drain as compared to the drain group. 
We also analyzedthe need for aspiration in patients with drain and no drain. 
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Table 9: Seromas requiring aspiration 
Aspiration Drain 
Frequency 
Percent 
 No drain Drain Total 
 No  10 
23.26 
 
24 
55.81 
 
34 
79.07 
 
 
Yes  7 
16.28 
 
2 
4.65 
 
9 
20.93 
 
 
Total 17 
39.53 
26 
60.47 
43 
100.00 
 
There was a significant need for aspiration in patients in the no drain group. 
In the non-drain arm, of the 9 patients detected to have seroma, 7 required 
aspirations. In the drain arm, of the 3 patients detected to have seroma, 2 required 
aspirations. No statistical significance was found. 
The mean volume aspirated in no drain arm was 28. 8 cc with a standard 
deviation of 19.9 whereas the mean volume aspirated in the drain arm was 
18.75cc with a standard deviation of 1.76.  There was no statistical significance 
found due to small number of seroma in the drain arm. 
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Table 10:Average volume aspirated 
drain 
 
N Mean Std Dev 
Minimu
m 
Maximu
m 
No 7 28.8571
429 
19.9054
312 
5.00000
00 
55.00000
00 
Yes  2 18.7500
000 
1.76776
70 
17.5000
000 
20.00000
00 
 
 
CORRELATION OF SEROMA WITH HISTOPATHOLOGY: 
 
The relation of seroma formation with the final histopathology was also 
compared and was not found to be significant. 
Though of the 4 malignant cases, 3 did develop seromas, this was not found to be 
statistically significant. 
Biopsy Frequency Percent 
basal cell adenoma 2 16.67 
low grade mucoepidermoid carcinoma 2 16.67 
malignant salivary neoplasm- mammary analogue 
carcinoma 
1 8.33 
mild chronic sialadenitis 1 8.33 
pleomorphic adenoma 4 33.33 
sinus tract with granulation tissue 1 8.33 
warthin's tumor 1 8.33 
TABLE 11: Histopathological correlation with seroma formation 
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Fig 10: histopathology of patients found to have seroma 
 
 
 
 
 
 
 
 
17%
17%
8%
8%
34%
8%
8%
Frequency
basal cell adenoma
low grade mucoepidermoid 
carcinoma
malignant salivary neoplasm-
mammary analogue carcinoma
mild chronic sialadenitis
pleomorphic adenoma
sinus tract with granulation 
tissue
warthin's tumor
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CORRELATION BETWEEN SEROMA AND OPERATING TIME 
 
The overall average operating time was 2 hours. 
The average operating time in the patients with seroma was around 2 hours and 
10 minutes while with patients with no seroma was less than 2 hours. 
There was no statistical difference between the two. 
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CORRELATION BETWEEN SISE OF THE LESION AND SEROMA 
FORMATION: 
 
The size of the specimen was recorded as per the pathologist and the length, 
breadth and depth were noted. Of the 43 patients, these details were not available 
for one patient. We derived the volume of the specimen from the three 
dimensions in order to see any correlation with size of the lesion and seroma 
formation. 
The mean length, breadth and depth were 5.17 cm, 3.81 cm and 2.34 cm 
respectively. 
The average length of specimen in patients with or without seroma was 5.0 and 
5.7 cm respectively. 
The average breadth of the specimen was 3.7 and 4.0 in patients with or without 
seroma.  
The average depth was 2.3 and 2.5 cms respectively for seroma and no seroma. 
 
The volume of the specimen was a product of the above three parameters. The 
minimum volume was 0.75 cc while the maximum volume was 130.2 cc. The 
Median volume was 45. 7 cc. The Quartiles were calculated for and found to be 
22.5 and 88.75 cc respectively. 
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Fig 12: comparison of the average dimensions of the specimen resected in 
patients with seroma as compared with no seroma. 
Table :Seroma formation Vs. volume of specimen 
Frequency 
Percent Volume of specimen 
 
Seroma 0-22.5 22.5-88.04 >88.04 Total 
No seroma 9 
21.43 
14 
33.33 
 
7 
16.67 
 
30 
71.43 
 
 
Seroma  2 
4.76 
 
7 
16.67 
 
3 
7.14 
 
12 
28.57 
 
 
Total 11 
26.19 
21 
50.00 
10 
23.81 
42 
100.00 
Frequency Missing = 1 
 
5.0
5.6
3.7
4.0
2.3
2.5
0.0
1.0
2.0
3.0
4.0
5.0
6.0
NO SEROMA SEROMA
LENGTH BREADTH DEPTH
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There was no significant difference in the incidence of seroma with respect to the 
specimen dimensions. 
AVERAGE TIME OF SUTURE REMOVAL 
It is routine practice to remove sutures in the head and neck region by the 5-
7
th
post-operative day. A majority of the patients had sutures removed on the 
7
th
post-operative day. 
 
The mean time for suture removal in patients with no seroma was 6.5 days while 
in patients with seroma was 7.5 days. There was no significant difference noted. 
12%
18%
53%
5%
12%
DATE OF SUTURE REMOVAL
5TH POD
6TH POD
7TH POD
8TH POD
9TH POD
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 INCIDENCE OF SURGICAL SITE INFECTION/ HAEMATOMA 
 There were no patients with surgical site infections or patients requiring 
antibiotics. 
 There were no patients with hematoma post operatively. 
 Of all the patients, 2 patients in the non-drain arm had gaping of the 
wound requiring resuturing. 
 Of the patients who presented with seroma, 2 patients in the non-drain 
arm required a drain to be placed to aid in the drainage of seroma, which 
was removed with reduction in drainage. 
 None of the patients had a prolonged stay in the hospital post operatively; 
however, 7 of the 43 patients recruited required repeated OPD visits and 
had a prolonged stay at Vellore. 
 Of the 7 patients having a prolonged stay, 6 were due to seroma and its 
management while 1 was for a histological surprise requiring treatment. 
 3 of the patients reported a seroma after discharge from OPD by 
telephonic or digital communication. None of the above required any 
intervention for the same. 
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DISCUSSION 
Various procedures have been described for benign pathology of the parotid 
gland, especially of the superficial lobe ranging from extra capsular 
parotidectomy, adequate parotidectomy to superficial parotidectomy. 
Conventionally, drains are placed after these surgeries to prevent 
seroma,sialocoele, or hematoma formation. There is no clear consensus regarding 
time of drain removal in terms of post-operative date or the volume drained. The 
outcomes under study i.e. Seroma, hematoma and surgical site infection have 
multiple contributing factors as per modern literature. 
 Even with the use of drains, the incidence of seroma formation has been found 
to vary from 2- 44 %. Various factors have been found to be associated such as 
the type of surgery, use of cautery, use of surgicel etc. Even the management of 
seromasis variable in different centers, with some opting for drainage, while 
some opting for conservative management. The implications of having drains 
placed are many. There is an additional scar which heals by secondary intention. 
There is an additional factor of patient discomfort, increased cost of treatment 
and a prolonged hospital stay.  As there was no conclusive evidence in modern 
literature proving the necessity of drains, we proceeded to study the same. 
We conducted non-inferiority, randomized controlled trial to evaluate the need to 
place drains in patients undergoing superficial parotidectomy andto compare the 
rates of seroma with and without drains. 
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CLINICALLY SIGNIFICANT SEROMA 
A clinically significant seroma was defined as a collection of clear fluid in the 
post-operative bed which requires intervention in the form of either aspirations or 
drain placement. This was based on clinical examination suggestive of swelling 
and fluctuation. 
No imaging was used and it was entirely based on clinical examination (presence 
of fluctuant swelling, serous discharge from the wound. 
Similar criteria have been studied with regards to breast surgeries. A 
retrospective study by Boostrom et al studied the incidence of clinically 
significant seroma in patients undergoing  either breast or axillary surgeries and 
looked at a total of 561 patients. Clinically significant seroma was defined as a 
post-operative fluid collection requiring one or more aspirations or drainage. The 
study compared the incidence of seroma in patients with drain as compared to no 
drain. Of the 252 patients with drain, 34 developed seroma while 13 of 309 non 
drain patients developed seroma. It was found that patients in the drain arm had a 
higher incidence of seroma post operatively.(47) 
A study by Michelotti et al analyzed clinically significant seroma following 
reconstruction in patients undergoing mastectomy with acellular dermis.  
Clinically significant seroma was defined as seromas arising post operatively 
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without any precipitating factors which on clinical judgment required drainage 
either in the operation theatre or the Outpatient department.(48) 
Of the 43 patients operated, we had 12 patients with clinically significant seroma 
requiring  an intervention. Of these, 9 patients were in no drain arm and 3 were in 
drain arm. The overall incidence rate was 27. 90 % with 20.9 % arising in the 
non-drain group. 
We further analyzed the same with respect to various other factors. 
 
PATHOLOGY AND SEROMA FORMATION 
Various studies have attempted to understand the relation between post-operative 
drainage and the final pathology.  Mofle and Urquhart found that the final 
pathology was related significantly to the incidence of seroma. Patients were 
noted to have a higher chance of seroma if the final biopsy was malignant and 
also had a prolonged hospital stay.(4) 
Noureai et al attempted to analyses the complications arising in patients operated 
on for benign pathology of the parotid gland. It was noted that there was a 
significantly higher incidence of salivary fistula and seroma in patients who were 
found to have sialadenitis.(6) 
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Malignant pathology was excluded as per our protocol. Of the 4 patients 
diagnosed to have low grade malignancies post operatively, 3 developed seroma. 
However, this was too small a size to show any statistical difference. 
We found no significant difference in the pathology of the patients in the drain 
and the non-drain arms.  
 
DRAIN REMOVAL 
Multiple studies have been conducted regarding the time of drain removal post 
operatively.  
Mofle et al emptied the surgical drains every 8 hours and a cut off of less than 15 
ml over 24 hours was defined and they noted a seroma incidence of 2%.(4)  Chen 
at al defined this cut off as removal once drainage is less than 10 ml over 24 
hours.(40) 
Jiang J et al removed the drain once the output was less than 20 ml over 24 hours 
and they found comparable seroma and salivary fistula formation in patients with 
pressure dressings or with suction drains.(41) 
Our unit protocol was to remove the drain once the output was less than 30 ml 
over 24 hours and we measured drain outputs 24 hourly.  The overall incidence 
of seroma was 27.90 %. 
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We found no co-relation between drain removal and seroma formation. Majority 
of the drains were removed within 48 hours of insertion: 7 of the 25 patients had 
drains removed within 24 hours while 12 of the 25 patients had drains removed 
at 48 hours. 
INTRA- OPERATIVE FACTORS 
The type of parotid surgery has been a matter of significant controversy over the 
past few years with regards to benefits and outcomes. 
A few authors have found the incidence of sialocoele formation to be 
significantly higher in patients undergoing partial superficial parotidectomy as 
compared to superficial parotidectomy due to remnant normal parenchyma.(43–
45). However, Koch et al compared long term complications and patients’ 
perception of the same following surgery and found complications to be 
significantly reduced following partial superficial parotidectomy. However as 
ours is a teaching institution, there is a variation in terms of surgeons and 
techniques.  Hence our aim was to analyses surgeries of the superficial lobe of 
the parotid gland. 
There is no literature to suggest that increased operating time leads to increased 
drain output or sarcomaformation. In our study, most patients were operated in a 
time range of 2-3 hours. There was a significant variation in operating time as 
surgeries performed by trainees were also included in the study. 
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There is literature which pertains to increased post-operative seroma or 
sialocoele formation with usage of cautery and surgicel. Herbert et al found a 
higher incidence of seroma with the use of surgicel (49). Lee et al compared 
multiple intra- operative factors such as tumor size and the use of sealing devices 
in patients undergoing partial superficial parotidectomy. Though there were more 
sialocoeles noted in patients having harmonic usage, this difference was not 
statistically significant. Furthermore they found that an anterior position of the 
tumor was the only statistically significant factor influencing sialocoele 
formation.(50)It was a routine practice for us to use bipolar cautery during the 
surgery. Surgicel usage was not evaluated.We also compared possible seroma 
formation with the specimen removed as an indirect indicator of extent of 
dissection. This was a derived variable wherein the length, breadth and depth of 
the specimen as per the pathologist were charted and multiplied. There was no 
significant increase in seroma formation with increase of volume of specimen 
excised.  
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MANAGEMENT OF SEROMA 
Classical management of seroma has been described as repeated aspiration of 
collected fluid and pressure dressings. 
Witt et al studied seroma formation in patients undergoing partial superficial 
parotidectomy as compared to near total parotidectomy. They advised 
management of seroma conservatively with observation as there was no 
significant relief following aspiration. It was noted that the seroma resolved 
within 1 month of the surgery irrespective of  aspiration.(44) 
We managed all seromas detected with needle aspiration, failing which drain was 
inserted to reduce the collection. A wide variation in the volume of fluid 
aspirated was noted in the non-drain arm ranging from 5- 55 cc. This may be due 
to an investigator’s bias as there may have been an earlier intervention in the 
patients with no drain. 
 
Hematoma was defined as a collection of blood in the operative bed. The 
incidence of hematomas following parotid gland has been found to be 0- 2 % as 
per current literature. We encountered no hematoma during our study. 
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Surgical site infection was defined as per CDC guidelines.(51) Theoretically a 
collection of fluid in the operative field may predispose to a surgical site 
infection. However this has not been validated as per current literature. As this is 
essentially a clean surgery with no contamination, there were no infections noted 
during the course of our study. 
Facial nerve paralysis is a common and disabling complication following surgery 
of the parotid gland.  Facial nerve palsy was evaluated using House Brackman 
scoring system evaluating three distributions of innervation of the face. There 
was no significant increase in facial nerve palsy noted .(46) 
 
Hospital stay : the incidence of sialocoele was found to have prolonged stay as 
per Mofle et al.(4) Multiple studies evaluating the use of drains in other parts of 
the body have found a longer hospital stay in patients with drains. The overall 
mean duration of stay was found to be 2.5 days. There was no significant 
difference in the duration of hospital stay in the patients with seroma. 
Wound gaping and resuturing was required for two of the patients in the non-
drain arm who presented with seroma. There was no available literature 
regarding these two parameters. 
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LIMITATIONS 
 
A. The estimated sample size was 100 with 50 in each arm.The study was 
powered to see a difference in the rate of seroma (non-inferiority trial). 
We could recruit only 43 patients during the study period and of the 43 
analyzed, there is an overwhelming evidence to suggest that the incidence 
of seroma formation is significantly higher in patients with no drain 
placed post operatively. 
B. Since this was a non-blinded, non-maskedstudy, a possible Hawthorne 
effect could not be excluded, i.e., a change in practice due to an awareness 
regarding being observed. 
C. At the time of the current study, no analysis was undertaken to compare 
any difference in seroma formation between various subtypes of parotid 
surgeries. 
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CONCLUSION 
 
There is a significant increase in the incidence of post-operative seroma when 
drains were not placed following superficial parotidectomy and we would 
advocate placing drains to prevent complications. The ideal cut-off volume to 
remove the drain is yet to be identified. 
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PROFORMA 
Performa 1:                                                     study id: 
Name:               gender: m/f 
Address: 
Contact no.:1.       
Preoperative evaluation: 
Side of mass: right/left/bilateral 
Duration of complaints:  <1 year/1-5 years/5-10 years/>10 years. 
Prior surgery for same condition: yes/no 
If yes:    < 1 year ago /> 1 year ago 
Ipsilateral /contralateral 
Comorbid conditions: please encircle if present: 
Hypertension/diabetes/chronic renal failure/thyroid/copd/obesity 
Examination of mass: size of mass: clinically ----------------- 
                                            radiologically: _______________ 
Prior FNAC histopathology:  performed at CMC/ slide review 
Clinical diagnosis: __________________________ 
Proposed surgery: _________________________ 
Consent for inclusion:                  Yes / No 
 
Performa 2: (TO BE FILED AT OR) 
Intraoperative factors: 
Block no.: 
Drain: yes/no 
Intraoperative findings: ____________________________________________________ 
Conversion to other procedure: total/ radical parotidectomy 
If yes, state reason: 
____________________________________________________________________________________ 
 
Performa 1:                                                   study id: 
Name:               Gender: m/f 
Address: 
Contact no.:1.    
       2.  
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Performa 3:   (to be filed at the ward) 
Post op: 
DRAIN/ NO DRAIN 
Drain functioning:  yes/no 
Drain output POD 2 POD 3 POD 4 POD 5 POD 6 
      
 
 Day of removal:   2 / 3/   4 / 5   / discharged with drain in situ 
Reason for removal: <30 ml/ surgeon’s discretion/ nonfunctional/ slipped out/others 
If others please state why: __________________________ 
Seroma: Yes / No               Hematoma:                 Yes / No 
If yes, noted on post op day: _____________ 
If yes, aspiration needed: yes/no    Volume aspirated: ___   
No. of aspirations required: _______ 
HMB SCORE: 
POD 2 POD 3 POD 4 POD5 
    
 
Discharge:  date of discharge: 
Patient discharged with drain:                                    Yes/ No 
Stay prolonged:                                                           Yes / No 
If yes: please state cause:    _____________________________ 
__________________________________________________                                                      
Any other complications: 
HMB SCORE: 
Performa 4: 
First opd visit:    
 DRAIN/ NO DRAIN 
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Removed:                                                             Yes / No 
Reason for removal: <30 ml/ surgeon’s discretion/ nonfunctional/ slipped out/others 
If others please state why: __________________________ 
COMPLICATIONS: 
Seroma: Yes / No               Hematoma:                 Yes / No 
If yes, noted on post op day: _____________ 
If yes, aspiration needed: yes/no    Volume aspirated: ___   
No. of aspirations required: _______ 
HMB SCORE: 
Wound site infection:                                             Yes / no 
Need for antibiotics:                                                Yes / no 
Wound gaping:                                                       Yes / No 
Resuturing:                        Yes /No 
Drainage of seroma done:                       Yes / No 
Suture removal:        Day 5/ day 6/ Day 7 
Biopsy report (with size of specimen): ______________________________________ 
____________________________________________________     
Wound site dehiscence:                                          Yes / No 
Wound site infection:                                               Yes / No 
Aspiration needed: yes/no    Volume aspirated: ___  
Need for repeated OPD visits: yes/no 
No. Of aspirations done: 
Discharge:  date of final discharge from OPD: 
Patient discharged with drain:                                   Yes / No 
Stay at Vellore prolonged:                                         Yes / No 
If yes: please state cause:    _____________________________ 
__________________________________________________                                                      
Any other complications: 
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CONSENT FORMS 
INFORMED CONSENT 
A Randomized Controlled Trial comparing the complication rates between having Drain in 
situ vs no drain in situ in patients undergoing Superficial Parotidectomy 
Information sheet 
 
You are being requested to participate in a trial evaluating the benefits and disadvantages of 
having drain in situ in patients undergoing superficial parotidectomy. Drains have been 
routinely utilized to evacuate the surgical site of any residual fluid or blood. However the 
benefits of having a drain placed have been recently questioned. Hence the investigators of this 
study would like to conduct a study that compares the benefits and disadvantages of having a 
drain placed in the post-operative period vs having no drain. 100 patients are expected to 
participate in said trial. 
 
What is a drain and its purpose following a surgery? 
A drain is a hollow tube made of silastic material placed under vacuum under the cover of the 
skin after tissue has been dissected out. 
A drain is frequently utilized to remove any excess fluid that may accumulate under the cover of 
the skin and soft tissue is blood or fluid that maybe normally collected in the region after a 
surgery is over. Drains are usually inserted at a site separate from the incision site and are 
removed on the post-operative day with minimal output or at surgeon's discretion. 
Having a drain placed may help to prevent any seroma formation which is the collection of clear 
fluid under the skin or a hematoma which is the collection of blood under the cover of the skin. 
What are the reasons for not placing a drain? 
Even after placing a drain in the postoperative bed, various hospitals document seroma 
formation up to 40 %. Also the rates of hematoma and infection rates are minimal with proper 
dissection irrespective of whether drain is placed or not. Also it is unknown if there is a known 
advantage of having a drain in preventing any of the said complications. 
Drains add to the cost of treatment and also lead to an additional scar at the site of the drain 
insertion. 
If you take part what will you have to do? 
If you agree to participate in this study, you will be assigned to different treatment groups in a 
random manner and neither you nor your treating doctor will be aware of which group you will 
come to lie in. At the end of the surgery a pre assigned envelope will decide whether drain is to 
be placed in situ or not. You shall be observed for any complications such as seroma, 
hematoma, infections or facial nerve abnormality till you are discharged. 
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You will be expected to come for a review to the hospital 1 week after the surgery and you will 
be observed for any of the said complications. No additional procedures or blood tests will be 
conducted routinely for this study.  
If at any time you experience any problems, you will be expected to report this to the doctor.  
Can you withdraw from this study after it starts? 
Your participation in this study is entirely voluntary and you are also free to decide to withdraw 
permission to participate in this study. If you do so, this will not affect your usual treatment at 
this hospital in any way. 
What will happen if you develop any study related injury? 
We do not expect any injury to happen to you but if you do develop any side effects or 
problems due to the study, these will be treated at no cost to you. We are unable to provide any 
monetary compensation, however.  
 
Will your personal details be kept confidential? 
The results of this study will be published in a medical journal but you will not be identified by 
name in any publication or presentation of results. However, your medical notes may be 
reviewed by people associated with the study, without your additional permission, should you 
decide to participate in this study. 
CONSENT TO TAKE PART IN A CLINICAL TRIAL 
Study Title:A Randomized Controlled Trial comparing use of drain vs. no drain in patients 
undergoing superficial parotidectomy. 
Study Number: 
Participant’s name: 
Date of Birth / Age (in years) 
I_____________________________________________________________ 
___________, wife/husband/ son/daughter of ___________________________________ 
(Please tick boxes) 
Declare that I have read the information sheet provide to me regarding this study and have 
clarified any doubts that I had. [ ] 
I also understand that my participation in this study is entirely voluntary and that I am free to 
withdraw permission to continue to participate at any time without affecting my usual treatment 
or my legal rights [ ] 
I also understand that neither I, nor my doctors, will have any choice or knowledge of whether I 
will be assigned to group having drain in situ or no drain  [ ]  
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I understand that I will receive free treatment for any study related injury or adverse event but I 
will not receive and other financial compensation [ ] 
I understand that the study staff and institutional ethics committee members will not need my 
permission to look at my health records even if I withdraw from the trial. I agree to this access [ 
]  
I understand that my identity will not be revealed in any information released to third parties or 
published [ ]  
I voluntarily agree to take part in this study [ ] 
 
Name: 
Signature: 
Date: 
 
Name of witness: 
Relation to participant: 
Date: 
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slno add sex som dur prior prioryes prioryes2 comrb htn dm crf thy copd obes diag random drain findlen findbred
1 andhra pradesh 1 1 1 0 0 pleomorphic adenoma1 1 2 2
2 jharkhand 2 2 2 0 0 basal cell adenoma 2 0 3 4
3 bangladesh 1 1 3 0 0 pleomorphic adenoma1 1 3 3
4 west bengal 1 1 2 0 1 0 1 0 0 0 0 pleomorphic adenoma2 1 3 3
5 west bengal 1 2 2 0 1 0 0 0 0 1 0 pleomorphic adenoma1 1 3 3
6 west bengal 1 1 2 0 0 pleomorphic adenoma1 1
7 tamil nadu 2 2 0 0 pleomorphic adenoma2 0 4 5
8 west bengal 2 2 1 0 1 1 0 0 0 0 0 left sialocoele 1 1
9 jharkhand 1 3 0 1 0 1 0 0 0 0 cystic tumor right parotid1 1 6 4
10 jharkhand 2 1 2 0 1 0 0 0 1 0 0 pleomorphic adenoma1 1 3 3
11 tamil nadu 1 1 1 0 0 pleomorphic adneoma2 0 2 1
12 west bengal 1 2 3 1 1 0 branchial fistula 2 0
13 tamil nadu 2 2 2 0 0 pleomorphic adenoma2 0 3 4
14 jharkhand 1 2 3 0 1 1 0 0 0 0 0 pleomorphic adenoma2 0 3 4
15 west bengal 1 1 1 0 1 0 1 0 0 0 0 warthin's tumor 2 0 3 2
west bengal 1 2 4 0 0 4 3
17 west bengal 2 2 4 0 1 0 1 0 0 0 0 cystic lymphangioma1 1 4 3
18 tamil nadu 2 2 1 0 0 pleomorphic adenoma1 1 3 3
19 tamil nadu 1 2 2 0 0 pleomorphic adenoma2 0 4 3
20 tripura 1 2 1 0 0 warthin's 2 0 2 3
21 jharkhand 1 1 3 0 0 pleomorphic adenoma1 1 4 4
22 andhra pradesh 1 1 2 0 0 warthin's tumor 2 0 3 4
23 bangladesh 2 2 2 0 0 pleomorphic adenoma2 0 4 3
24 jharkhand 1 1 1 0 1 1 1 0 0 0 0 basaloid neoplasm
25 west bengal 2 2 2 0 0 pleomorphic adenoma2 0 3 3
26 tamil nadu 1 2 2 0 0 pleomorphic adenoma1 1 7 4
27 kerela 2 2 2 0 0 pleomorphic adenoma1 1 3 2
28 jharkhand 1 2 4 1 2 1 0 pleomorphic adenoma2 0 3 3
29 west bengal 1 1 4 0 0 plemorphic adenoma1 1
30 tamil nadu 1 2 4 0 0 pleomorphic adenoma1 1 3 3
31 west bengal 2 1 3 0 1 1 0 0 0 0 0 1.6 2 0 2 2
32 tamil nadu 1 1 1 0 0 pleomorphic adenoma1 1 4 4
33 west bengal 1 1 4 0 0 pleomorphic adenoma1 1
34 west bengal 1 3 1 0 0 warthin's tumor 1 1
35 west bengal 1 3 1 1 1 2 0 warthin's tumor 2 0 2 2
36 west bengal 1 1 2 0 0 pleomorphic adenoma1 1 3 2
37 jharkhand 1 1 2 0 0 pleomorphic adenoma1 1 4 4
38 andhra pradesh 1 2 1 0 0 pleomorphic adenoma1 1 2 1
39 west bengal 1 1 2 0 1 0 1 0 0 1 0 warthin's tumor 2 0 5 5
40 tamil nadu 1 1 2 0 1 0 1 0 0 0 0 pleomorphic adenoma1 1 2 3
41 tamil nadu 2 2 1 0 0 pleomorphic adenoma2 0 3 3
42 andhra pradesh 2 1 2 0 0 pleomorphic adenoma1 1 3 3
43 west bengal 1 1 1 0 1 0 1 0 0 0 0 warthn's tumor 1 1 2 2
44 west bengal 1 1 2 0 1 1 0 0 1 0 0 pleomorphic adenoma2 1 6 6
45 west bengal 1 2 2 0 0 pleomorphic adenoma1 1 4 4
or time convert convertyes drain1 draind1 draind2 draind3 draind4 drainrem drainremreser heam asp vol no hmb2 hmb5 dds ds
1:55 0 1 75 50 3 1 0 0 0 121 121 4/28/2014 0
2:00 0 0 1 0 0 222 222 5/3/2014 0
2:00 0 1 10 10 3 1 0 0 0 111 111 5/4/2015 0
2:00 0 1 80 75 40 4 1 0 0 0 111 111 5/10/2014 0
1:15 0 1 25 3 1 0 0 0 111 111 5/10/2015 0
1:55 0 1 75 70 50 30 5 1 0 0 0 666 666 5/15/2014 0
1:00 0 0 0 0 0 112 112 5/24/2014 0
1:29 1 35 30 3 1 1 0 1 20 1 112 112 6/18/2014 0
1:00 0 1 35 3 1 0 0 0 115 115 10/4/2014 0
2:00 1 50 30 3 1 0 0 0 112 112 9/27/2014 0
2:30 0 0 0 0 0 0 0 222 222 9/25/2014 0
2:30 0 0 1 0 1 30 1 112 112 10/12/2014 0
1:45 0 0 0 0 0 223 223 11/7/2014 0
1:00 0 0 0 0 0 223 223 10/29/2014 0
3:30 0 0 0 0 0 234 234 10/12/2014 0
1 malignant lesion
1:40 0 1 80 70 50 30 4 1 0 0 0 112 112 6/14/2014 0
1:30 0 1 10 2 1 0 0 0 111 111 9/8/2014 0
1:29 0 0 0 0 0 111 111 8/2/2014 0
2:25 0 0 0 0 0 111 111 11/12/2014 0
2:00 0 1 50 40 3 1 0 0 0 213 113 11/27/2014 0
2:10 0 0 1 0 1 50 1 111 111 12/6/2014 0
2:20 0 0 0 0 113 113 6/27/2014 0
1 suspicion of malignancy
2:00 0 0 0 0 0 112 11/6/2014 0
2:00 0 1 50 30 3 1 0 0 0 0 111 111 12/15/2014 0
2:20 0 1 90 90 75 80 4 4 0 0 0 223 223 1/18/2015 0
3:00 0 0 0 0 0 111 111 1/17/2015 0
2:00 0 1 30 0 3 1 0 0 0 113 3/7/2015 0
2:00 0 1 50 30 3 1 0 0 111 111 3/5/2015 0
2:00 0 0 1 0 0 113 113 3/27/2015 0
2:15 0 1 30 3 1 0 0 0 111 111 3/27/2015 0
2:30 0 1 50 30 6 0 0 0 111 111 4/12/2015 1
1:30 0 1 20 2 1 0 0 0 111 111 5/18/2015 0
1:30 0 0 0 0 0 111 111 4/26/2015 0
1:30 0 1 30 2 1 0 0 0 111 111 4/2/2015 0
2:30 0 1 50 10 3 1 0 0 0 112 112 4/17/2015 0
1:40 0 1 5 2 1 0 0 111 111 5/9/2015 0
2:15 0 0 0 0 112 112 6/6/2015 0
2:00 0 1 50 25 3 1 0 0 0 111 111 6/28/2015 0
1:30 0 0 0 0 234 234 5/14/2015 0
2:00 0 1 5 2 1 0 0 111 111 5/28/2015 0
2:00 0 1 10 2 1 0 0 0 111 111 6/13/2015 0
2:30 0 1 0 1 30 2 113 113 6/13/2015 0
2:10 0 1 29 2 1 0 0 0 111 111 6/11/2015 0
hospstay prolong drremov drainrem1 ser1 heam1 asp1 vol1 no1 hmb ssi antib gape resutur sutremov biopsy specleng spec bread specdept dehies
4 0 0 0 0 0 121 0 0 0 0 7 warthin's tumor 5.8 4 2 0
4 0 0 0 0 0 222 0 0 0 0 9 basal cell adenoma 4 3.5 2.5 0
3 0 1 1 0 0 0 111 0 0 0 0 7 salivary gland fatty infilteration5 4.5 2 0
4 0 1 0 0 111 0 0 0 0 7 pleomorphic adenoma6.2 5.3 3 0
4 0 1 0 0 0 111 0 0 0 0 7 pleomorphic adenoma6 4.8 2.8 0
2 0 1 1 0 0 0 555 0 0 0 0 7 pleomorphic adenoma5 4.5 2 0
2 0 0 0 0 662 0 0 0 0 7 pleomorphic adenoma6 4.5 1 0
6 0 1 0 0 0 113 0 0 0 0 7 mild chronic sialadenitis5 3 1.5 0
4 0 1 0 0 0 115 0 0 0 0 5 basal cell adenoma 7 2.5 5 0
4 0 1 0 0 0 111 0 0 0 0 7 pleomorphic adenoma4 4 1.7 0
2 0 1 0 1 25 3 222 0 0 0 1 7 malignant salivary neoplasm- mammary analogue carcinoma7.5 4 1.6 0
3 0 1 0 1 25 2 112 0 0 0 0 7 sinus tract with granulation tissue6 4 2 0
3 0 1 0 1 12 5 133 0 0 0 0 7 pleomorphic adenoma7 4 3.5 0
2 0 0 0 223 0 0 0 0 6 myoepithelioma 6.5 6 3 0
3 0 0 0 113 0 0 0 0 7 warthin's tumor 4 2 1.5 0
4 0 1 0 0 0 112 0 0 0 0 8 low grade mucoepidermoid carcinoma4.5 3.5 1.2 0
4 0 0 0 0 0 111 0 0 0 0 6 pleomorphic adenoma2.5 1.7 1.5 0
2 0 0 0 0 0 111 0 0 0 0 7 pleomorphic adenoma4.5 4 2.5 0
2 0 0 0 111 0 0 0 0 7 warthin's tumor 3 3 1.5 0
2 0 1 0 0 0 111 0 0 0 0 7 pleomorphic adenoma6.4 4 3.4 0
2 0 0 1 0 0 111 0 0 0 0 9 warthin's tumor 6 4 2.8 0
3 0 0 1 0 1 50 2 111 0 0 1 1 7 pleomorphic adenoma7 4.5 3.5 1
2 0 0 0 0 112 0 0 0 0 5 pleomorphic adenoma4.3 3.7 2.7 0
4 0 1 0 0 0 111 0 0 0 0 6 kimura's disease 8 5 3.2 0
3 0 1 0 0 0 223 0 0 0 0 5 pleomorphic adenoma6.5 4 2.5 0
2 0 1 0 1 5 3 111 0 0 0 0 9 pleomorphic adenoma5 4 1.5 0
4 0 1 0 0 0 113 0 0 0 0 7 pleomorphic adenoma7 6 3 0
2 0 1 0 0 0 111 0 0 0 0 7 pleomorphic adenoma5 4.5 3 0
3 0 0 1 0 0 114 0 0 0 0 7 low grade mucoepidermoid carcinoma3 3 2 0
3 0 0 0 0 0 111 0 0 0 0 9 pleomorphic adenoma4 3 3 0
3 0 1 1 0 0 0 111 0 0 0 0 7 basal cell adenoma 6 4.3 3 0
2 0 1 0 0 0 111 0 0 0 0 6 warthin's tumor 4 2.5 2 0
3 0 0 0 0 0 111 0 0 0 0 5 warthin's tumor 2.8 2.2 2 0
2 0 1 0 0 0 111 0 0 0 0 7 basal cell adenoma 0
3 0 1 0 0 0 112 0 0 0 0 5 pleomorphic adenoma8 5 1 0
4 0 1 0 0 0 111 0 0 0 0 8 pleomorphic adenoma1.5 1 0.5 0
2 0 0 0 0 0 112 0 0 0 0 6 warthin's tumor 6 5 4 0
3 0 1 0 0 0 111 0 0 0 0 7 lipoma parotid 5.5 3.5 3 0
2 0 0 1 0 1 55 3 234 0 0 0 0 9 low grade mucoepidermoid carcinoma6 4 2 0
2 0 1 0 0 0 111 0 0 0 0 7 pleomorphic adenoma3 2.5 0.56 0
2 0 1 0 0 0 111 0 0 0 0 6 warthin's tumor 1.3 1 0.6 0
2 0 1 0 1 5 1 113 0 0 0 0 6 pleomorphic adenoma5 6.2 4.2 0
2 0 1 0 0 0 111 0 0 0 0 6 pleomorphic adenoma6.5 4.5 3.4 0
2.883721
asp2 vol2 no2 opdrepeat finds prolong1 return serds interven
0 0 0 0 0 0
0 0 5/12/2014 0 0 0 0
0 0 5/8/2014 0 0 0 0
0 0 5/15/2014 0 0 0 0
0 0 5/12/2015 0 0 0 0
0 1 5/22/2014 0 0 0 0
0 0 6/26/2014 0 0 0 0
0 0 6/18/2014 0 0 0 0
0 0 10/9/2014 0 0 0 0
0 0 10/2/2014 0 0 0 0
0 1 10/16/2014 1 1 0 0
0 0 10/16/2014 0 0 0 0
0 1 11/24/2014 1 1 0 0
0 0 11/3/2014 0 0 0 0
0 0 10/16/2014 0 0 0 0
0 0 6/26/2014 1 0 0 0
0 0 9/18/2014 0 0 0 0
0 0 8/14/2015 0 0 0 0
0 0 11/20/2014 0 0 0 0
0 12/4/2014 0 0 0 0
1 30 4 1 1/12/2015 1 0 0 0
1 50 3 1 7/14/2014 1 0 0 0
0 0 11/10/2014 0 0 0 0
0 0 12/22/2014 0 0 0 0
0 0 1/19/2015 0 0 0 0
0 1 1/29/2015 1 0 0 0
0 0 3/12/2015 0 0 0 0
0 0 3/16/2015 0 0 0 0
0 0 4/2/2015 0 0 0 0
0 0 4/9/2015 0 0 0 0
0 0 5/4/2015 0 1 1 0
0 0 4/30/2015 0 0 0 0
0 0 4/30/2015 0 0 0 0
0 0 4/9/2015 0 0 0 0
0 0 4/23/2015 0 0 0 0
0 0 6/22/2015 0 0 0 0
0 0 6/11/2015 0 0 0 0
0 0 7/2/2015 0 0 0 0
0 1 5/21/2015 1 0 1 1
0 0 7/6/2015 0 0 0 0
0 0 6/18/2015 0 0 0 0
0 0 6/18/2015 0 0 0 0
0 0 6/8/2015 0 0 0 0
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OBJECTIVES: 
This prospective randomized clinical trial was conducted to evaluate the necessity of drainage after 
superficial parotidectomy for benign parotid disorders. 
METHODS: 
 From 2013-2015, all patients who underwent total superficial parotidectomy for benign parotid 
disorders were randomly allocated to be drained or not, post-operatively. Operative and postoperative 
outcomes including complications (seroma, hematoma), necessity for aspiration of seroma, re-suturing 
and hospital stay were all assessed. The sample size was ascertained to be 50 in each arm and the 
allocation was on the basis of computer generated opaque envelopes.  
RESULTS: 
25 patients were in the drain arm while 17 had no drain placed. The Incidence of seroma was analyzed 
on the basis of ITT and per protocol analysis. We found a statistically significant increased incidence of 
seroma formation, needing repeated aspiration in the patients with no drains. We analyzed various 
other factors such as operating time, the HPE report, and size of specimen and found no statistical 
correlation with the formation of seroma.  
CONCLUSION: 
These findings suggest that postoperative complications are increased when postoperative drainage is 
not done following superficial parotidectomy. In the light of these findings, the routine use of drains is 
recommended following parotid surgeries. 
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